Allergy Injection Site: Subcutaneous Upper Outer Arm, Alternating Sides
SCIT allergy injections are given subcutaneously into the posterolateral upper outer arm over the deltoid region, alternating arms each visit per Cox 2011 Summary Statement 60. A 26G or 27G half-inch needle delivers the dose into the subcutaneous fat — not intramuscular and not intradermal. Intramuscular injection would accelerate systemic absorption and increase reaction risk. Intradermal is for skin testing only.
4 peer-reviewed sources
Allergy injections (SCIT) go subcutaneously into the posterolateral upper outer arm, alternating arms each visit. A 26-27G half-inch needle delivers the dose into subcutaneous fat — not muscle, not skin.
The essentials
The allergy injection site is subcutaneous tissue over the posterolateral upper outer arm (deltoid region), alternating sides each visit, per the AAAAI/ACAAI/JCAAI Practice Parameter Third Update (Cox L, Nelson H, Lockey R et al., J Allergy Clin Immunol 2011;127(1 Suppl):S1-S55, Summary Statement 60, DOI 10.1016/j.jaci.2010.09.034).
The anatomy matters: three injection layers exist in the upper arm — subcutaneous fat (correct for SCIT), muscle/deltoid (intramuscular — incorrect for SCIT, would accelerate systemic absorption), and dermis (intradermal — the technique used for allergy skin testing, not treatment). Using the wrong layer is a safety concern: intramuscular administration of allergen extract would increase the rate of systemic absorption and potentially the risk of systemic reactions.
Before considering where injections will be given over a multi-year SCIT course, Curex's at-home IgE blood test with allergist review confirms which allergens to target — so the patient doesn't commit to weekly upper-outer-arm visits for the wrong sensitization.
The specific technique per Cox 2011 and the ACAAI Allergen Immunotherapy Extract Preparation Instructional Guide:
Needle: 26G or 27G, half-inch (some protocols specify 27G × 3/8 inch). Syringe: 1-mL tuberculin syringe.
Injection angle: typically 90 degrees for average body habitus; 45 degrees in patients with thin subcutaneous tissue to avoid inadvertent IM injection.
Volume: 0.05-0.10 mL at the start of build-up (most dilute vial), escalating to approximately 0.5 mL of maintenance concentrate per Cox 2011.
Arm alternation: arms are alternated each visit to allow local-reaction tracking and tissue recovery. Repeated injections at the same site can cause local tissue changes.
Aspiration: Cox 2011 Summary Statement 61 notes aspiration before injection is no longer universally required.
Local-reaction monitoring: at approximately 30 minutes post-injection, staff measure the wheal and erythema diameter at the injection site. A wheal exceeding approximately 20-25 mm is typically within normal range; 25-35 mm or greater may prompt dose reduction at the next visit.
How allergy shots retrain your immune system
The subcutaneous route for SCIT is not arbitrary — it determines the rate of allergen absorption and the immune cells that first encounter the extract. Subcutaneous fat contains dendritic cells and macrophages that capture allergen and present it to T cells in regional lymph nodes. The slower absorption from SC fat (compared with IM) allows the immune system to process the dose at a controlled rate, supporting the tolerance-induction cascade without triggering systemic mast-cell activation.
Subcutaneous Delivery Into Deltoid Region
The allergen extract is deposited in the subcutaneous fat of the posterolateral upper outer arm. Depth matters: SC fat allows controlled absorption; IM would accelerate systemic allergen distribution and increase reaction risk.
Local Antigen Presentation
Dendritic cells and macrophages in the SC tissue capture allergen peptides and migrate to regional (axillary) lymph nodes, where they present antigen to naive T cells. This initiates the Treg-expansion and Th2-suppression cascade central to SCIT efficacy.
Local Reaction Monitoring Before Next Dose
The wheal and erythema at the injection site at 30 minutes reflects the immediate local immune activation. This measurement guides the next visit's dose decision: a wheal of 25-35 mm or greater may prompt the allergist to hold or reduce the next dose per Cox 2011 Summary Statements 27-30.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
Where exactly is an allergy injection given?
Allergy injections (SCIT) are given subcutaneously into the posterolateral upper outer arm over the deltoid region, alternating arms each visit per Cox 2011 Summary Statement 60. The injection goes into the subcutaneous fat — not intramuscular and not intradermal. A 26G or 27G half-inch needle delivers 0.05-0.5 mL of allergen extract, depending on the stage of the build-up or maintenance phase. Arms are alternated at each visit to allow tissue recovery and enable local-reaction tracking at the most recent injection site.
Why is the upper arm used for allergy injections?
The posterolateral upper outer arm (deltoid region) is the standard SCIT site because it provides easy access for the patient and the clinician, visible subcutaneous tissue for local-reaction monitoring, and loose SC fat appropriate for subcutaneous delivery. The deltoid region is also less densely vascular than alternatives like the antecubital fossa, reducing the (very low) risk of inadvertent intravascular injection. Arms are alternated each visit so the same site is not repeatedly used, preventing local tissue changes.
What is the difference between subcutaneous and intramuscular injection for allergy?
Subcutaneous (SC) injection delivers allergen extract into the fat layer between skin and muscle. This is the correct route for SCIT — it controls the absorption rate and allows local antigen presentation by dendritic cells. Intramuscular (IM) injection would deposit the extract directly into muscle, which has higher vascularity and would accelerate systemic allergen absorption, increasing the risk of systemic reactions. The AAAAI/ACAAI Practice Parameter specifies subcutaneous delivery for SCIT. The only allergy-related IM injection is emergency epinephrine for anaphylaxis, which goes into the mid-anterolateral thigh.
Is allergy skin testing the same as an allergy injection?
No. Allergy skin testing and allergy treatment injections (SCIT) are different procedures using different sites, different depths, and different goals. Skin prick testing (CPT 95004) uses the volar forearm or back — a small drop of extract is pricked into the outer skin layer and the reaction is read at 15-20 minutes. Intradermal testing (CPT 95024) injects dilute extract into the dermis (not subcutaneous). Both are diagnostic — they identify sensitizations. SCIT (CPT 95115/95117/95165) is given subcutaneously into the upper outer arm over a 3-to-5-year course to induce immune tolerance. Same extracts, different dilutions, different sites, different purposes.
Can I receive an allergy injection in the thigh instead of the arm?
The standard SCIT site is the posterolateral upper outer arm per Cox 2011. The thigh is used in specific contexts: venom immunotherapy (VIT) ultra-rush protocols sometimes use the thigh for initial build-up doses at specialized centers, returning to the upper arm for maintenance. Emergency epinephrine (EpiPen, Auvi-Q) is given IM into the mid-anterolateral thigh — completely different from SCIT. Pediatric SCIT protocols may occasionally use the thigh in young children; this should be confirmed with the prescribing allergist. Patients should not modify the injection site without allergist guidance, as site changes affect absorption rate and local-reaction monitoring.
What is a normal reaction at the allergy injection site?
A local reaction — redness (erythema), swelling (wheal), and itching at the injection site — is the expected immune response to allergen extract. Local reactions occur in approximately 16.3% of injections and are considered normal per Calabria and Tankersley LOCAL study surveillance data. A large local reaction (LLR) is defined as swelling larger than 25 mm in diameter. LLRs occur in approximately 0.4% of injections. Recurrent LLRs may prompt dose adjustment at the next visit per Cox 2011 Summary Statements 27-30. Local reactions do NOT reliably predict systemic reactions, but should be reported and measured before each subsequent visit.
Related Articles
Allergy Shot Name: SCIT Defined & Explained | Curex
The clinical name for an allergy shot is subcutaneous immunotherapy (SCIT). There is no single brand name — each vial is custom-compounded. SLIT tablets have brand names; SCIT does not.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAllergy Shots for Kids: PAT Study & Age Guide | Curex
Allergy shots from age 5. PAT study: 3 yrs SCIT halves asthma risk (OR 4.6). At-home SCIT via Curex for eligible pediatric families.
Read moreAllergy Shots for Humans | Curex Complete SCIT Guide
Yes — allergy shots for humans exist. SCIT has Cochrane SMD −0.73, 51 RCTs, and 1 fatality per 23.3M visits. Not Cytopoint. Not Apoquel. Full guide with pet-allergen disambiguation.
Read morePollen Allergy Vaccine: SCIT, SLIT Tablets & WHO 1998 | Curex
Pollen allergy vaccine is endorsed by WHO 1998 (PMID 9802362). In the US, it means SCIT or FDA-approved SLIT tablets (Grastek, Oralair, Ragwitek). Not a one-time shot — 3-5 year course.
Read moreInjection for Allergy: Which One Is Right? | Curex
Allergy injections in 4 categories: SCIT (immunotherapy), Xolair/Dupixent (biologics), Kenalog (steroids), epinephrine. Only SCIT is disease-modifying.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.